A carregar...
The role of idecabtagene vicleucel in patients with heavily pretreated refractory multiple myeloma
The development of several treatment options over the last 2 decades has led to a notable improvement in the survival of patients with multiple myeloma. Despite these advances, the disease remains incurable for most patients. Moreover, standard combinations of alkylating agents, immunomodulatory dru...
Na minha lista:
| Publicado no: | Ther Adv Hematol |
|---|---|
| Main Authors: | , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
SAGE Publications
2021
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8170343/ https://ncbi.nlm.nih.gov/pubmed/34104374 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/20406207211019622 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|